This bridge program will now allow Medicare beneficiaries access to GLP-1 medications for weight loss through a monthly subscription model, which raises important questions about who pays, how much it will cost, and whether the program can be sustained long term, Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek
Vitamin E serum levels can be assessed to confirm deficiency and must be monitored in patients at high risk of insufficiency
Publisher | Google Scholor Markowiak-Kope P, liewska K
The ATF4-mediated upregulation of amino acid transporters and one-carbon metabolism, including SLC1A1, SLC7A8 , and SHMT2 , presumably increases the supply of glutamate, cysteine, and glycine, which might act in concert for the biosynthesis of GSH
SURMOUNT-5 Trial Results This Phase 3b, open-label trial randomized 751 adults with obesity (but without diabetes) to receive either: Maximum tolerated dose of tirzepatide (10 mg or 15 mg) Maximum tolerated dose of semaglutide (1.7 mg or 2.4 mg) Key findings at 72 weeks: The trial concluded that tirzepatide was superior to semaglutide with respect to reduction in body weight and waist circumference at week 72